Biophytis is participating to:
– The Geneva European Midcap digital event, December 1rst & 2 2020
– The “Anticovid” Biotech sector conference organized by the SFAF on Wednesday, December 9
– The 13th International SCWD virtual conference, December 11-13 2020
Biophytis to evaluate BIO101’s potential to limit weight regain in its OBA clinical study in obesity
Biophytis today announces that it has submitted to the Brazilian Health Regulatory Agency (ANVISA) an amendment to the protocol of the phase 2 OBA clinical study in obesity.
